cholic acid and liraglutide

cholic acid has been researched along with liraglutide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Cahen, DL; Diamant, M; Groen, AK; Hoekstra, T; Kramer, MH; Muskiet, MH; Nieuwdorp, M; Smits, MM; Tonneijck, L; van Raalte, DH	1
Briand, F; Combes, G; Duparc, T; Martinez, LO; Merian, J; Najib, S; Sulpice, T; Trenteseaux, C	1
Bao, X; Chen, Y; Lin, L; Pan, T; Qian, K; Wang, H; Wang, Z; Xu, M; Yao, P	1

Trials

1 trial(s) available for cholic acid and liraglutide

Article	Year
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:12 Topics: Aged; Bile Acids and Salts; Blood Glucose; Chenodeoxycholic Acid; Cholic Acid; Deoxycholic Acid; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Fasting; Feces; Female; Gallbladder; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Liraglutide; Male; Metformin; Middle Aged; Organ Size; Postprandial Period; Sitagliptin Phosphate; Sulfonylurea Compounds; Ultrasonography; Ursodeoxycholic Acid	2016

Article

Year

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.

Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:12

Topics: Aged; Bile Acids and Salts; Blood Glucose; Chenodeoxycholic Acid; Cholic Acid; Deoxycholic Acid; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Fasting; Feces; Female; Gallbladder; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Liraglutide; Male; Metformin; Middle Aged; Organ Size; Postprandial Period; Sitagliptin Phosphate; Sulfonylurea Compounds; Ultrasonography; Ursodeoxycholic Acid

2016

Other Studies

2 other study(ies) available for cholic acid and liraglutide

Article	Year
Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis. American journal of physiology. Gastrointestinal and liver physiology, 2019, 10-01, Volume: 317, Issue:4 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Cholesterol, Dietary; Cholic Acid; Diet; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Liraglutide; Liver; Liver Cirrhosis; Metabolic Diseases; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease	2019
Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery. Journal of nanobiotechnology, 2023, Jan-16, Volume: 21, Issue:1 Topics: Animals; Cholic Acid; Diabetes Mellitus, Type 2; Glycolipids; Hypoglycemic Agents; Intestinal Mucosa; Liraglutide; Mice; Molecular Docking Simulation; Nanocomposites; Zein	2023

Article

Year

Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.

American journal of physiology. Gastrointestinal and liver physiology, 2019, 10-01, Volume: 317, Issue:4

Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Cholesterol, Dietary; Cholic Acid; Diet; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Liraglutide; Liver; Liver Cirrhosis; Metabolic Diseases; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease

2019

Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery.

Journal of nanobiotechnology, 2023, Jan-16, Volume: 21, Issue:1

Topics: Animals; Cholic Acid; Diabetes Mellitus, Type 2; Glycolipids; Hypoglycemic Agents; Intestinal Mucosa; Liraglutide; Mice; Molecular Docking Simulation; Nanocomposites; Zein

2023